Stempeutics gets process patent from Japan for stem cell-based drug

New Delhi: Stempeutics Research, a company part-owned by Cipla Ltd, said on Monday that it has won a process patent from the Japan Patent Office for its stem cell-based drug Stempeucel. The novelty covers the method of preparing master cell banks, working …

[Read the full article here]

Comments are closed.